INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Non-Current Assets History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹11 Cr | ₹8.97 Cr | ₹8.10 Cr | ₹5.27 Cr | ₹2.77 Cr |
What is the latest Total Non-Current Assets ratio of INDO US BIOTECH ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹11 Cr |
Mar2023 | ₹8.97 Cr |
Mar2022 | ₹8.10 Cr |
Mar2021 | ₹5.27 Cr |
Mar2020 | ₹2.77 Cr |
How is Total Non-Current Assets of INDO US BIOTECH Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹11 Cr | 19.34 | |
Mar2023 | ₹8.97 Cr | 10.73 | |
Mar2022 | ₹8.10 Cr | 53.68 | |
Mar2021 | ₹5.27 Cr | 90.46 | |
Mar2020 | ₹2.77 Cr | - |
Compare Total Non-Current Assets of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹306.5 Cr | -3.6% | 3.7% | -19.6% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,151.0 Cr | -4.3% | -4.8% | 17.2% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,473.6 Cr | -4.4% | -9.7% | 36.7% | Stock Analytics | |
VENKYS (INDIA) | ₹2,261.5 Cr | -1.7% | -0.5% | -13.9% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,377.6 Cr | -4.3% | -6.5% | -30.7% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹464.3 Cr | -3.4% | 12.2% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | -3.6% |
3.7% |
-19.6% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses